olfactory receptor family 11 subfamily M member 1 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR11M1P profile across patient tissues and cancer cell-line models. OR11M1P expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in DLBC. Among the 18 cancer types available for tumor–normal comparison, OR11M1P is differentially expressed in 4, with the highest sampling consensus in BRCA. Additionally, OR11M1P RNA expression shows 7,728 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight DLBC, BRCA, and THYM as cancer lineages where OR11M1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR11M1P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR11M1P survival associations across molecular data types. OR11M1P RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR11M1P RNA expression–survival associations across cancer types. High OR11M1P expression shows unfavorable associations in DLBC, PCPG, OV and ACC, but favorable associations in HNSC and LGG. The DLBC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify DLBC as the clearest survival context for OR11M1P RNA expression.
This table summarizes OR11M1P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for OR11M1P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR11M1P shows higher tumor expression in BRCA, HNSC, BLCA and LUSC. The BRCA box plot shows higher OR11M1P RNA expression in tumor versus normal tissue (log2 FC = +0.036, t-test p = .009).
This table shows molecular features associated with OR11M1P in patient tissues and cancer cell lines. In patient samples, OR11M1P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
